Haemonetics Corporation Common Stock (HAE)
71.24
+2.32 (3.37%)
Haemonetics Corporation is a global healthcare company that specializes in providing innovative blood management solutions
The company develops and manufactures a range of systems and products designed to optimize the collection, processing, and transfusion of blood and its components. Haemonetics focuses on enhancing blood safety and efficiency within healthcare settings, offering technologies that support blood donation and transfusion processes, as well as promoting the overall health of patients through effective blood management practices. Their commitment to improving patient outcomes and supporting healthcare providers makes them a key player in the field of healthcare technology.
Frequently Asked Questions
Is Haemonetics Corporation Common Stock publicly traded?
Yes, Haemonetics Corporation Common Stock is publicly traded.
What exchange does Haemonetics Corporation Common Stock trade on?
Haemonetics Corporation Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Haemonetics Corporation Common Stock?
The ticker symbol for Haemonetics Corporation Common Stock is HAE on the New York Stock Exchange
What is the current price of Haemonetics Corporation Common Stock?
The current price of Haemonetics Corporation Common Stock is 71.24
When was Haemonetics Corporation Common Stock last traded?
The last trade of Haemonetics Corporation Common Stock was at 7:00 pm EST on February 5th, 2025
What is the market capitalization of Haemonetics Corporation Common Stock?
The market capitalization of Haemonetics Corporation Common Stock is 3.64B
How many shares of Haemonetics Corporation Common Stock are outstanding?
Haemonetics Corporation Common Stock has 51.03M shares outstanding.